IBDEI116 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1515,0)
 ;;=PAIN^29^100
 ;;^UTILITY(U,$J,358.4,1516,0)
 ;;=PREVENTIVE HEALTH^30^100
 ;;^UTILITY(U,$J,358.4,1517,0)
 ;;=PULMONARY^31^100
 ;;^UTILITY(U,$J,358.4,1518,0)
 ;;=SEXUAL TRAUMA^32^100
 ;;^UTILITY(U,$J,358.4,1519,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^100
 ;;^UTILITY(U,$J,358.4,1520,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^100
 ;;^UTILITY(U,$J,358.4,1521,0)
 ;;=SUBSTANCE DISORDERS^35^100
 ;;^UTILITY(U,$J,358.4,1522,0)
 ;;=VARICOSE VEINS^36^100
 ;;^UTILITY(U,$J,358.4,1523,0)
 ;;=WOMEN'S HEALTH^37^100
 ;;^UTILITY(U,$J,358.4,1524,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^38^100
 ;;^UTILITY(U,$J,358.4,1525,0)
 ;;=COMA^7^100
 ;;^UTILITY(U,$J,358.4,1526,0)
 ;;=CAUSES OF INJURY^6^100
 ;;^UTILITY(U,$J,358.4,1527,0)
 ;;=DEMENTIA^8^100
 ;;^UTILITY(U,$J,358.4,1528,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^24^100
 ;;^UTILITY(U,$J,358.4,1529,0)
 ;;=BLOODS, ARTERIAL & VENOUS^1^101
 ;;^UTILITY(U,$J,358.4,1530,0)
 ;;=OXIMETRY (WHEN ONLY SERVICE)^7^101
 ;;^UTILITY(U,$J,358.4,1531,0)
 ;;=PULMONARY FUNCTION TESTING^9^101
 ;;^UTILITY(U,$J,358.4,1532,0)
 ;;=THORACENTESIS^11^101
 ;;^UTILITY(U,$J,358.4,1533,0)
 ;;=RESPIRATORY THERAPY^10^101
 ;;^UTILITY(U,$J,358.4,1534,0)
 ;;=BRONCHOSCOPY^2^101
 ;;^UTILITY(U,$J,358.4,1535,0)
 ;;=EXERCISE TESTING^3^101
 ;;^UTILITY(U,$J,358.4,1536,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^101
 ;;^UTILITY(U,$J,358.4,1537,0)
 ;;=IMMUNIZATIONS^5^101
 ;;^UTILITY(U,$J,358.4,1538,0)
 ;;=TRACHEOSTOMY^12^101
 ;;^UTILITY(U,$J,358.4,1539,0)
 ;;=PROLONGED SVC W/O PT^8^101
 ;;^UTILITY(U,$J,358.4,1540,0)
 ;;=MISCELLANEOUS^6^101
 ;;^UTILITY(U,$J,358.4,1541,0)
 ;;=NEW PATIENT^2^102
 ;;^UTILITY(U,$J,358.4,1542,0)
 ;;=ESTABLISHED PATIENT^1^102
 ;;^UTILITY(U,$J,358.4,1543,0)
 ;;=CONSULTATIONS^3^102
 ;;^UTILITY(U,$J,358.4,1544,0)
 ;;=COMMON PULMONARY DX^1^103
 ;;^UTILITY(U,$J,358.4,1545,0)
 ;;=SLEEP DISORDERS^20^103
 ;;^UTILITY(U,$J,358.4,1546,0)
 ;;=OBSTRUCTIVE SLEEP APNEA^13^103
 ;;^UTILITY(U,$J,358.4,1547,0)
 ;;=OTHER^26^103
 ;;^UTILITY(U,$J,358.4,1548,0)
 ;;=CANCER^2^103
 ;;^UTILITY(U,$J,358.4,1549,0)
 ;;=CARDIAC^3^103
 ;;^UTILITY(U,$J,358.4,1550,0)
 ;;=ENDOCRINE^4^103
 ;;^UTILITY(U,$J,358.4,1551,0)
 ;;=ENT^5^103
 ;;^UTILITY(U,$J,358.4,1552,0)
 ;;=GASTROINTESTINAL^5^103
 ;;^UTILITY(U,$J,358.4,1553,0)
 ;;=GENITOURINARY/RENAL^6^103
 ;;^UTILITY(U,$J,358.4,1554,0)
 ;;=HEMATOLOGIC/LYMPHATIC^7^103
 ;;^UTILITY(U,$J,358.4,1555,0)
 ;;=HEPATIC/BILIARY^8^103
 ;;^UTILITY(U,$J,358.4,1556,0)
 ;;=INFECTIOUS DISEASE^9^103
 ;;^UTILITY(U,$J,358.4,1557,0)
 ;;=INTERSTITIAL LUNG DISEASE^10^103
 ;;^UTILITY(U,$J,358.4,1558,0)
 ;;=MUSCULOSKELETAL^11^103
 ;;^UTILITY(U,$J,358.4,1559,0)
 ;;=SUTURES^23^103
 ;;^UTILITY(U,$J,358.4,1560,0)
 ;;=RADIATION^19^103
 ;;^UTILITY(U,$J,358.4,1561,0)
 ;;=OCCUPATIONAL^15^103
 ;;^UTILITY(U,$J,358.4,1562,0)
 ;;=PAIN^16^103
 ;;^UTILITY(U,$J,358.4,1563,0)
 ;;=PLEURAL DISEASE^17^103
 ;;^UTILITY(U,$J,358.4,1564,0)
 ;;=PSYCHIATRIC/BEHAVIORAL^18^103
 ;;^UTILITY(U,$J,358.4,1565,0)
 ;;=SKIN^22^103
 ;;^UTILITY(U,$J,358.4,1566,0)
 ;;=NEUROLOGIC^12^103
 ;;^UTILITY(U,$J,358.4,1567,0)
 ;;=OBSTRUCTIVE DISEASE^14^103
 ;;^UTILITY(U,$J,358.4,1568,0)
 ;;=VASCULAR^24^103
 ;;^UTILITY(U,$J,358.4,1569,0)
 ;;=SYMPTOMS^21^103
 ;;^UTILITY(U,$J,358.4,1570,0)
 ;;=NEW PATIENT^2^104
 ;;^UTILITY(U,$J,358.4,1571,0)
 ;;=ESTABLISHED PATIENT^1^104
 ;;^UTILITY(U,$J,358.4,1572,0)
 ;;=CONSULTATIONS^3^104
 ;;^UTILITY(U,$J,358.4,1573,0)
 ;;=THERAPY MODALITIES/PROCEDURES^12^105
 ;;^UTILITY(U,$J,358.4,1574,0)
 ;;=INJECTIONS/DRUGS^5^105
 ;;^UTILITY(U,$J,358.4,1575,0)
 ;;=ORTHOTIC DEVICES^8^105
 ;;^UTILITY(U,$J,358.4,1576,0)
 ;;=KINESIOTHERAPY^6^105
 ;;^UTILITY(U,$J,358.4,1577,0)
 ;;=THERAPY EVALUATIONS^11^105
 ;;^UTILITY(U,$J,358.4,1578,0)
 ;;=WOUND CARE^13^105
 ;;^UTILITY(U,$J,358.4,1579,0)
 ;;=CARDIAC REHAB^1^105
 ;;^UTILITY(U,$J,358.4,1580,0)
 ;;=EDUCATION/TRAINING^2^105
 ;;^UTILITY(U,$J,358.4,1581,0)
 ;;=HOME THERAPY SERVICES^4^105
 ;;^UTILITY(U,$J,358.4,1582,0)
 ;;=NEUROMUSCULAR TESTING^7^105
 ;;^UTILITY(U,$J,358.4,1583,0)
 ;;=TEAM CONFERENCE^10^105
 ;;^UTILITY(U,$J,358.4,1584,0)
 ;;=HEALTH BEHAVIORS^3^105
 ;;^UTILITY(U,$J,358.4,1585,0)
 ;;=RECREATION THERAPY^9^105
 ;;^UTILITY(U,$J,358.4,1586,0)
 ;;=AMPUTATION STATUS^1^106
 ;;^UTILITY(U,$J,358.4,1587,0)
 ;;=BRAIN DISORDERS^2^106
 ;;^UTILITY(U,$J,358.4,1588,0)
 ;;=CARDIOPULMONARY^4^106
 ;;^UTILITY(U,$J,358.4,1589,0)
 ;;=COMPLICATIONS DUE TO^5^106
 ;;^UTILITY(U,$J,358.4,1590,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^106
 ;;^UTILITY(U,$J,358.4,1591,0)
 ;;=Z CODES^20^106
 ;;^UTILITY(U,$J,358.4,1592,0)
 ;;=BRAIN INJURY - TRAUMATIC^3^106
 ;;^UTILITY(U,$J,358.4,1593,0)
 ;;=FEMUR/THIGH/KNEE FRACTURE^7^106
 ;;^UTILITY(U,$J,358.4,1594,0)
 ;;=FOOT/TOE/ANKLE FRANCTURE^8^106
 ;;^UTILITY(U,$J,358.4,1595,0)
 ;;=HAND/FINGER FRACTURE^9^106
 ;;^UTILITY(U,$J,358.4,1596,0)
 ;;=HIP/PELVIS FRACTURE^10^106
 ;;^UTILITY(U,$J,358.4,1597,0)
 ;;=HUMERUS/SHOULDER FRACTURE^11^106
 ;;^UTILITY(U,$J,358.4,1598,0)
 ;;=TIBIA/FIBULA FRACTURE^18^106
 ;;^UTILITY(U,$J,358.4,1599,0)
 ;;=SPINE FRACTURE^16^106
 ;;^UTILITY(U,$J,358.4,1600,0)
 ;;=WRIST/FOREARM FRACTURE^19^106
 ;;^UTILITY(U,$J,358.4,1601,0)
 ;;=OTHER FRACTURE^13^106
 ;;^UTILITY(U,$J,358.4,1602,0)
 ;;=PAIN^14^106
 ;;^UTILITY(U,$J,358.4,1603,0)
 ;;=SPINAL CONDITIONS^15^106
 ;;^UTILITY(U,$J,358.4,1604,0)
 ;;=SYMPTOMS^17^106
 ;;^UTILITY(U,$J,358.4,1605,0)
 ;;=FALLS^6^106
 ;;^UTILITY(U,$J,358.4,1606,0)
 ;;=ASPIRATION/INJECTION^1^107
 ;;^UTILITY(U,$J,358.4,1607,0)
 ;;=INJECTION MEDICATIONS^2^107
 ;;^UTILITY(U,$J,358.4,1608,0)
 ;;=ULTRASOUND^3^107
 ;;^UTILITY(U,$J,358.4,1609,0)
 ;;=NEW PATIENT^2^108
 ;;^UTILITY(U,$J,358.4,1610,0)
 ;;=ESTABLISHED PATIENT^1^108
 ;;^UTILITY(U,$J,358.4,1611,0)
 ;;=CONSULTATIONS^3^108
 ;;^UTILITY(U,$J,358.4,1612,0)
 ;;=COMMON DIAGNOSES^1^109
 ;;^UTILITY(U,$J,358.4,1613,0)
 ;;=CRYSTAL ARTHROPATHIES^2^109
 ;;^UTILITY(U,$J,358.4,1614,0)
 ;;=JOINT DISORDERS^6^109
 ;;^UTILITY(U,$J,358.4,1615,0)
 ;;=MISCELLANEOUS^7^109
 ;;^UTILITY(U,$J,358.4,1616,0)
 ;;=NERVOUS SYSTEM^8^109
 ;;^UTILITY(U,$J,358.4,1617,0)
 ;;=OSTEOARTHRITIS^9^109
 ;;^UTILITY(U,$J,358.4,1618,0)
 ;;=OSTEOMYELITIS^10^109
 ;;^UTILITY(U,$J,358.4,1619,0)
 ;;=OSTEOPOROSIS^11^109
 ;;^UTILITY(U,$J,358.4,1620,0)
 ;;=PYOGENIC ARTHRITIS^13^109
 ;;^UTILITY(U,$J,358.4,1621,0)
 ;;=SPINE DISORDERS^14^109
 ;;^UTILITY(U,$J,358.4,1622,0)
 ;;=TENDINITIS & BURSITIS^15^109
 ;;^UTILITY(U,$J,358.4,1623,0)
 ;;=VASCULAR DISORDERS^16^109
 ;;^UTILITY(U,$J,358.4,1624,0)
 ;;=VASCULITIS CONDITIONS^17^109
 ;;^UTILITY(U,$J,358.4,1625,0)
 ;;=INFECTIONS^3^109
 ;;^UTILITY(U,$J,358.4,1626,0)
 ;;=INT DERANGEMENT OF KNEE^4^109
 ;;^UTILITY(U,$J,358.4,1627,0)
 ;;=OTHER INFLAMMATORY^12^109
 ;;^UTILITY(U,$J,358.4,1628,0)
 ;;=HISTORY OF^5^109
 ;;^UTILITY(U,$J,358.4,1629,0)
 ;;=ESTABLISHED PATIENT^1^110
 ;;^UTILITY(U,$J,358.4,1630,0)
 ;;=GROUP TREATMENT^8^111
 ;;^UTILITY(U,$J,358.4,1631,0)
 ;;=VOICE PROSTHESES^23^111
 ;;^UTILITY(U,$J,358.4,1632,0)
 ;;=AAC DEVICES^1^111
 ;;^UTILITY(U,$J,358.4,1633,0)
 ;;=OTHER PROCEDURES^13^111
 ;;^UTILITY(U,$J,358.4,1634,0)
 ;;=LARYNGOSCOPY PROCEDURES^9^111
 ;;^UTILITY(U,$J,358.4,1635,0)
 ;;=NASOPHARYNGOSCOPY^12^111
 ;;^UTILITY(U,$J,358.4,1636,0)
 ;;=DYSPHAGIA EVALUATION^5^111
 ;;^UTILITY(U,$J,358.4,1637,0)
 ;;=SPECIAL OTORHINOLARYNGOLOGIC SERVICES^17^111
 ;;^UTILITY(U,$J,358.4,1638,0)
 ;;=SCREENING^15^111
 ;;^UTILITY(U,$J,358.4,1639,0)
 ;;=ATTENTION G-CODES^2^111
 ;;^UTILITY(U,$J,358.4,1640,0)
 ;;=CARRY,MOVE,HANDLE OBJECTS^3^111
 ;;^UTILITY(U,$J,358.4,1641,0)
 ;;=CHANGE/MAINTAIN BODY POSITION^4^111
 ;;^UTILITY(U,$J,358.4,1642,0)
 ;;=EDUCATION^6^111
 ;;^UTILITY(U,$J,358.4,1643,0)
 ;;=FITTING/ORIENTATION DEVICE^7^111
 ;;^UTILITY(U,$J,358.4,1644,0)
 ;;=MEMORY G-CODES^10^111
 ;;^UTILITY(U,$J,358.4,1645,0)
 ;;=MOBILITY G-CODES^11^111
 ;;^UTILITY(U,$J,358.4,1646,0)
 ;;=SPEECH LANGUAGE PATHOLOGY^14^111
 ;;^UTILITY(U,$J,358.4,1647,0)
 ;;=SELF-CARE G-CODES^16^111
 ;;^UTILITY(U,$J,358.4,1648,0)
 ;;=SPEECH G-CODES^18^111
 ;;^UTILITY(U,$J,358.4,1649,0)
 ;;=SPOKEN LANGUAGE EXPRESSION G-CODES^19^111
 ;;^UTILITY(U,$J,358.4,1650,0)
 ;;=SPOKEN LANGUAGE G-CODES^20^111
 ;;^UTILITY(U,$J,358.4,1651,0)
 ;;=SWALLOWING G-CODES^21^111
 ;;^UTILITY(U,$J,358.4,1652,0)
 ;;=VOICE G-CODES^22^111
 ;;^UTILITY(U,$J,358.4,1653,0)
 ;;=DEVELOPMENTAL DISORDERS^1^112
 ;;^UTILITY(U,$J,358.4,1654,0)
 ;;=LATE EFFECTS OF CEREBROVASCULAR DISEASE^2^112
 ;;^UTILITY(U,$J,358.4,1655,0)
 ;;=VOCAL FOLD DISORDERS^3^112
 ;;^UTILITY(U,$J,358.4,1656,0)
 ;;=SWALLOWING DISORDERS^4^112
 ;;^UTILITY(U,$J,358.4,1657,0)
 ;;=SPEECH DISORDERS^5^112
 ;;^UTILITY(U,$J,358.4,1658,0)
 ;;=REASON FOR VISIT/HEALTH STATUS^6^112
 ;;^UTILITY(U,$J,358.4,1659,0)
 ;;=PSYCHIATRIC THERAPY^8^113
 ;;^UTILITY(U,$J,358.4,1660,0)
 ;;=OTHER^7^113
 ;;^UTILITY(U,$J,358.4,1661,0)
 ;;=CASE MANAGEMENT SERVICES^1^113
 ;;^UTILITY(U,$J,358.4,1662,0)
 ;;=HOME HEALTH VISIT^5^113
 ;;^UTILITY(U,$J,358.4,1663,0)
 ;;=COMMUNITY RESIDENTIAL CARE^2^113
 ;;^UTILITY(U,$J,358.4,1664,0)
 ;;=SMOKING/TOBACCO USE CESSATION^9^113
 ;;^UTILITY(U,$J,358.4,1665,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^4^113
 ;;^UTILITY(U,$J,358.4,1666,0)
 ;;=EDUCATION/TRAINING^3^113
 ;;^UTILITY(U,$J,358.4,1667,0)
 ;;=TEAM CONFERENCE^10^113
 ;;^UTILITY(U,$J,358.4,1668,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^114
 ;;^UTILITY(U,$J,358.4,1669,0)
 ;;=ANXIETY DISORDERS^2^114
 ;;^UTILITY(U,$J,358.4,1670,0)
 ;;=BIPOLAR DISORDERS^3^114
 ;;^UTILITY(U,$J,358.4,1671,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^114
 ;;^UTILITY(U,$J,358.4,1672,0)
 ;;=DEPRESSIVE DISORDERS^7^114
 ;;^UTILITY(U,$J,358.4,1673,0)
 ;;=DISSOCIATIVE DISORDERS ^9^114
 ;;^UTILITY(U,$J,358.4,1674,0)
 ;;=FEEDING & EATING DISORDERS^12^114
 ;;^UTILITY(U,$J,358.4,1675,0)
 ;;=EDUCATIONAL/OCCUPATIONAL PROBLEMS^10^114
 ;;^UTILITY(U,$J,358.4,1676,0)
 ;;=GENDER DYSPHORIA^14^114
 ;;^UTILITY(U,$J,358.4,1677,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^114
 ;;^UTILITY(U,$J,358.4,1678,0)
 ;;=MEDICATION-INDUCED MOVEMENT DISORDERS^16^114
